IXICO plc

AIM:IXI Rapport sur les actions

Capitalisation boursière : UK£8.8m

IXICO Résultats passés

Passé contrôle des critères 0/6

IXICO's earnings have been declining at an average annual rate of -34.8%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 2.4% per year.

Informations clés

-34.8%

Taux de croissance des bénéfices

-34.8%

Taux de croissance du BPA

Life Sciences Croissance de l'industrie36.9%
Taux de croissance des recettes-2.4%
Rendement des fonds propres-18.6%
Marge nette-31.1%
Dernière mise à jour des bénéfices31 Mar 2024

Mises à jour récentes des performances passées

Recent updates

Is IXICO plc (LON:IXI) Potentially Undervalued?

Sep 30
Is IXICO plc (LON:IXI) Potentially Undervalued?

Is It Time To Consider Buying IXICO plc (LON:IXI)?

Apr 13
Is It Time To Consider Buying IXICO plc (LON:IXI)?

If You Like EPS Growth Then Check Out IXICO (LON:IXI) Before It's Too Late

Feb 25
If You Like EPS Growth Then Check Out IXICO (LON:IXI) Before It's Too Late

Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock

Nov 20
Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock

Should You Think About Buying IXICO plc (LON:IXI) Now?

Oct 25
Should You Think About Buying IXICO plc (LON:IXI) Now?

Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock

Aug 11
Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock

Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock

Apr 17
Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock

IXICO plc (LON:IXI) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Mar 24
IXICO plc (LON:IXI) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

At UK£1.04, Is It Time To Put IXICO plc (LON:IXI) On Your Watch List?

Mar 22
At UK£1.04, Is It Time To Put IXICO plc (LON:IXI) On Your Watch List?

Does IXICO's (LON:IXI) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 22
Does IXICO's (LON:IXI) Statutory Profit Adequately Reflect Its Underlying Profit?

Did Business Growth Power IXICO's (LON:IXI) Share Price Gain of 146%?

Feb 01
Did Business Growth Power IXICO's (LON:IXI) Share Price Gain of 146%?

Will Weakness in IXICO plc's (LON:IXI) Stock Prove Temporary Given Strong Fundamentals?

Jan 09
Will Weakness in IXICO plc's (LON:IXI) Stock Prove Temporary Given Strong Fundamentals?

I Ran A Stock Scan For Earnings Growth And IXICO (LON:IXI) Passed With Ease

Dec 22
I Ran A Stock Scan For Earnings Growth And IXICO (LON:IXI) Passed With Ease

Who Has Been Selling IXICO plc (LON:IXI) Shares?

Dec 04
Who Has Been Selling IXICO plc (LON:IXI) Shares?

What Does IXICO plc's (LON:IXI) Share Price Indicate?

Jul 06
What Does IXICO plc's (LON:IXI) Share Price Indicate?

Ventilation des recettes et des dépenses

Comment IXICO gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

AIM:IXI Recettes, dépenses et bénéfices (GBP Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Mar 246-241
31 Dec 236-241
30 Sep 237-141
30 Jun 237-141
31 Mar 238041
31 Dec 228141
30 Sep 229141
30 Jun 228141
31 Mar 228141
31 Dec 219141
30 Sep 219241
30 Jun 2110141
31 Mar 2110151
31 Dec 2010151
30 Sep 2010151
30 Jun 209151
31 Mar 209141
31 Dec 198141
30 Sep 198041
30 Jun 197041
31 Mar 196041
31 Dec 186041
30 Sep 185-131
30 Jun 185-131
31 Mar 185-131
31 Dec 174-131
30 Sep 174-231
30 Jun 174-231
31 Mar 174-232
31 Dec 164-232
30 Sep 163-232
30 Jun 163-231
31 Mar 163-231
31 Dec 153-131
30 Sep 153-131
31 Mar 153-131
31 Dec 143-131
30 Sep 143-221

Des revenus de qualité: IXI is currently unprofitable.

Augmentation de la marge bénéficiaire: IXI is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: IXI is unprofitable, and losses have increased over the past 5 years at a rate of 34.8% per year.

Accélération de la croissance: Unable to compare IXI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: IXI is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).


Rendement des fonds propres

ROE élevé: IXI has a negative Return on Equity (-18.59%), as it is currently unprofitable.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé